Abstract
Toxic epidermal necrolysis (TEN) is a rare and acute life-threatening condition and one of the severe cutaneous adverse drug reactions. There are limited data on TEN from the COVID-19 vaccine regarding its pathogenesis, treatment, and prognosis, particularly in children. We report a case of COVID-19 vaccine-induced TEN and the patient’s human leukocyte antigen pharmacogenomic profile.
Keywords: COVID-19 vaccine; pharmacogenomics; toxic epidermal necrolysis.
All Keywords
【저자키워드】 COVID-19 vaccine, pharmacogenomics, toxic epidermal necrolysis., 【초록키워드】 COVID-19, Treatment, Pathogenesis, Prognosis, children, Antigen, Adverse drug reactions, leukocyte, life-threatening, toxic, the patient, epidermal, 【제목키워드】 vaccination, BNT162b2, Pfizer-BioNTech, Toxic epidermal necrolysis, first dose,
【저자키워드】 COVID-19 vaccine, pharmacogenomics, toxic epidermal necrolysis., 【초록키워드】 COVID-19, Treatment, Pathogenesis, Prognosis, children, Antigen, Adverse drug reactions, leukocyte, life-threatening, toxic, the patient, epidermal, 【제목키워드】 vaccination, BNT162b2, Pfizer-BioNTech, Toxic epidermal necrolysis, first dose,